CerviGuard proof
Live workspace, repository, and MDR draft are visible.
Visitors can review CerviGuard through its live workspace, public repository, screenshots, MDR draft, and trust material.
Healthcare AI companyCerviGuard live product
Research-driven healthcare AI products with live clinical software.
SmartClover is a digital-native healthcare AI product company that develops and owns CerviGuard and DataGems. Both have live public product surfaces; TealGuard and NIS2COMPASS are approved consortium R&D programmes advancing SmartClover's current and future products.
CerviGuard workspace proofThe live workspace entry at cerviguard.link, captured from the running product.
Product evidence and working routes
SmartClover links the live CerviGuard workflow to research context, trust material, and direct commercial paths for clinics, research partners, and investors.
Research context
Cervical-screening research stays source-linked.
Two PubMed references are linked for visitors who want context on cervical screening participation and follow-up work in Romania.
Research track
DataGems sits below the product story.
DataGems gives research partners a concrete surface for synthetic-data workflow discussions after the CerviGuard path is clear.
Products and applied research
CerviGuard is the flagship live product. DataGems is the live synthetic-data research product. TealGuard and NIS2COMPASS extend SmartClover's product and research roadmap through approved consortium R&D.
Flagship product
CerviGuard
A live product for structured cervical screening workflows, AI-assisted review, and clinician-led follow-up.
Live product
DataGems
A live product for synthetic-data workflows, schema drafting, configured generation jobs, and reviewable exports.
Public research directions
Cancer prevention and decision support
SmartClover publicly discusses cancer prevention, secondary prophylaxis, early detection, and treatment-optimization research as active directions, not as released products.
Founder and research credibility
SmartClover's product work starts from cervical-screening research.
Founder Dr. Andreea Damian leads SmartClover from Cluj-Napoca with CerviGuard as the flagship product. The research links below are kept as context for the cervical-screening problem space; current product details come from CerviGuard, product, and trust pages.
PubMed 35197342 covers follow-up barriers after abnormal cervical screening results.PubMed 28460211 covers barriers to cervical screening participation in Romania.CerviGuard, GitHub, Hugging Face, and trust routes are available before outreach.
Source-linked materials
Source-linked proof visitors can inspect before outreach.
2022 PubMed recordFollow-up barriers after abnormal cervical screening results.2017 PubMed recordBarriers to cervical screening participation in Romania.CerviGuard repositoryPublic implementation context for the flagship workflow product.TealGuard project websiteOfficial project information, objectives, partners, evidence, and updates.
Public timeline: from screening research to a live product
These milestones connect the published screening research, the CerviGuard build, and how SmartClover works today.
2017 publication
Screening participation barriers documented
Social Science & Medicine published field research on Roma women and cervical screening participation in Romania.
2022 publication
Follow-up barriers researched in remote communities
BMJ Open published a protocol on facilitators and barriers to follow-up after abnormal cervical screening results in remote Romanian communities.
2024-2026 product build-out
CerviGuard moved into a live product surface
The public product surface, repository, and model hub provide a concrete flagship proof layer with supporting artifacts.
Current routes
Choose the right conversation
Contact, pricing, how-to-buy, proof, regulatory, and trust routes help each visitor decide where to start.
Clear next steps for buyers, partners, and investors
The site keeps one primary CTA while making audience-specific entry points clear for buyers, partners, and investors.
Book demo / Request pilot
For clinics, hospitals, and operators evaluating CerviGuard or a scoped product rollout.
Go to contact hubResearch partnership
For institutions exploring prevention, qualitative research, or model-development collaboration.
Go to contact hubInvestor inquiry
For investors and accelerators reviewing SmartClover's healthcare AI platform and public product evidence.
Go to contact hubTrust, proof, and buying routes
Everything a buyer, partner, or investor needs to vet SmartClover before reaching out.